Vaxxinity, Inc. (VAXX)
NASDAQ: VAXX · IEX Real-Time Price · USD
0.718
+0.029 (4.14%)
At close: Mar 28, 2024, 4:00 PM
0.720
+0.002 (0.35%)
After-hours: Mar 28, 2024, 6:42 PM EDT

Vaxxinity Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Revenue
000.070.560
Revenue Growth (YoY)
---88.15%--
Cost of Revenue
001.940.050
Gross Profit
00-1.870.510
Selling, General & Admin
22.3928.3551.8312.223.01
Research & Development
35.947.6371.3820.5710.66
Operating Expenses
58.2975.98123.232.7913.66
Operating Income
-58.29-75.98-125.08-32.28-13.66
Interest Expense / Income
0.70.510.841.180.44
Other Expense / Income
-2.05-1.2711.266.490.07
Pretax Income
-56.93-75.22-137.18-39.96-14.16
Income Tax
00000.06
Net Income
-56.93-75.22-137.18-39.96-14.22
Shares Outstanding (Basic)
127126776653
Shares Outstanding (Diluted)
127126776653
Shares Change
0.45%64.44%16.68%23.31%-
EPS (Basic)
-0.45-0.60-1.79-0.61-0.27
EPS (Diluted)
-0.45-0.60-1.79-0.61-0.27
Free Cash Flow
-58.04-57.79-82.31-35.39-12.27
Free Cash Flow Per Share
-0.46-0.46-1.07-0.54-0.23
Gross Margin
---2834.85%90.66%-
Operating Margin
---189507.58%-5795.69%-
Profit Margin
---207840.91%-7173.61%-
Free Cash Flow Margin
---124709.09%-6353.14%-
EBITDA
-54-73.02-135.23-38.06-13.62
EBITDA Margin
---204898.48%-6832.68%-
Depreciation & Amortization
2.231.681.10.720.11
EBIT
-56.24-74.71-136.34-38.78-13.73
EBIT Margin
---206568.18%-6961.40%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).